Methods: 99 patients underwent TAVI (78.8% trans-femoral, 12.1% trans-apical/aortic and 9.1% subclavian access) between February 2009 and September 2011 at Rennes University Hospital. Creatinine level was assessed daily at least up to 72 hours after TAVI. the characteristics of patients, procedural features and outcomes according to VARC definitions were studied to evaluate determinants and prognostic impact of AKI. Results: AKI occurred in 22 patients (22.2%). Among them, 5 were AKI 2 (5.1%), 8 were AKI 3 (9.1%) including 4 who needed dialysis (4%). At baseline, compared to no AKI or AKI 1, AKI 2 or 3 patients had a higher prevalence of Ն grade 2 mitral regurgitation (pϭ0.03). There was a non significant trend toward a higher prevalence of moderate or severe chronic kidney disease (pϭ0.07). During the post TAVI hospitalization, AKI 2 or 3 was related to a higher rate of death from any cause (pϭ0.0009), major bleeding, acute heart failure (both pϭ0.002), infectious complications (pϭ0.0008) and longer total and ICU hospitalization duration (pϭ0.0004 and Ͻ0.0001 respectively). There was no association between any stage of AKI and the 30-day and 6-months rate of death. Only AKI 3 was associated with a higher risk of 6-months NYHA class III or IV (pϭ0.016). Conclusions: AKI 2 or 3 as defined by the VARC criteria were associated with a higher risk of post procedural death because of their association with other major post procedural complications. AKI 3 was associated with a higher risk of short term worse functional outcomes.
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Trend of clinical outcomes in patients with chronic kidney disease and endstage renal disease following percutaneous coronary intervention. Table 1 . Over the 12 year period, there was a significant decrease in the rates of bleeding (group 1: 19.3%, group 2: 12.6%, group 3: 9.3%, pϽ0.00001), MI (7.7%, 3.9%, 2.0%, pϽ 0.0001) and MACE (27.1%, 18.3%, 15.1%, pϽ0.00001). Although rates of stroke and mortality were lower in the 2 most recent cohorts compared with those patients treated before, this trend was not statistically significant.
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Conclusions:
In a large registry of patients with CKD and ESRD who have undergone PCI, the trend in clinical outcomes of bleeding and MI have improved over a span of 12 years. Further studies are warranted to understand contributing factors for these improvements. 
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Background: In patients undergoing primary PCI for STEMI, the occurrence of CIN has a pronounced impact both on morbidity and mortality. We investigated the variables associated with the development of CIN in patients with STEMI undergoing primary PCI. We then evaluated the predictive accuracy of a 3-variable clinical risk score (the AGEF score) based on age, left ventricular ejection fraction (LVEF) and estimated glomerular filtration rate (eGFR), as compared with EuroSCORE and Mehran Risk Score (MRS).
Methods: 481 consecutive patients with STEMI who were undergoing primary PCI were prospectively enrolled. CIN was defined as an absolute increase in serum creatinine Ն0.5 mg/dL or an increase Ն25% from baseline within 72 hours after the administration of contrast medium. AGEF score was calculated by adding 1 point to the Age/EF(%) ratio if the eGFR was Ͻ60 mL/min per 1.73 m 2 . Logistic regression, receiver-operating characteristic (ROC) curve analysis and Hosmer-Lemeshow 2 statistic were performed to assess accuracy and calibration of AGEF score, EuroSCORE and MRS as predictors of CIN. Results: The incidence of CIN was 5.2%. In-hospital mortality was higher among patients with CIN (16% Vs 1.3%, pϭ0.001). At multivariable analysis age (OR 1.08, pϭ0.038), eGFR (OR 0.95, pϭ0.002), LVEF (OR 0.94, pϭ0 .033) and post-procedural TIMI flow (OR 0.30, pϭ0 .01) were independent predictors of CIN. AGEF score was an accurate (OR 5.19, pϽ0.0001, AUC 0.88) and well calibrated (Hosmer-Lemeshow 2ϭ10.24, pϭ0.62) predictor of CIN with a 100% sensitivity for AGEF score Ͼ1.5 point; all patients developing CIN were in the highest tertile of AGEF score (pϽ0.0001). MRS (OR 1.27, pϽ0.0001) and EuroSCORE (OR 1.61, pϽ0.0001) were less accurate, though not significantly, predictors of CIN than AGEF score. Conclusions: Age, LVEF and eGFR are independent predictors of CIN development after primary PCI for STEMI. A simple model based on pre-procedural, readily obtainable variables, such the AGEF score, can predict the risk of CIN at least as accurately as more complex non-linear risk scores and is well fitted to the acute settings. Complex risk models may be over fitted, at least in populations with a low rate of events. 
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